Prelude Therapeutics Incorporated

NASDAQ:PRLD

1.27 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -121.832-115.438-111.694-56.929-27.57-14.68
Depreciation & Amortization 1.1691.3240.9150.5420.3820.149
Deferred Income Tax -3.47301.364000
Stock Based Compensation 0.02625.14420.9315.5830.8460.18
Change In Working Capital -10.4790.9323.6254.6160.6671.382
Accounts Receivables 000000
Inventory 000000
Accounts Payables -2.27-0.3473.9031.1570.5460.721
Other Working Capital -8.2091.279-0.2783.4590.1210.661
Other Non Cash Items 1.9364.3091.3280.0110.010.015
Operating Cash Flow -107.063-83.729-83.531-46.177-25.665-12.954
Investing Activities:
Investments In Property Plant And Equipment -3.513-3.019-2.323-0.621-0.78-0.529
Acquisitions Net 0.031-0.0850000
Purchases Of Investments -221.633-119.223-261.48000
Sales Maturities Of Investments 190.5203.9330000
Other Investing Activites -0.0310.085-0.261000
Investing Cash Flow -34.64681.691-263.803-0.621-0.78-0.529
Financing Activities:
Debt Repayment 000-0.258-0.1240
Common Stock Issued 135.7310.389161.424166.6329.85317.937
Common Stock Repurchased -000000
Dividends Paid 000000
Other Financing Activities 0.6640.4263.47379.8560.0317.937
Financing Cash Flow 136.3950.815164.897246.22829.72917.937
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -5.314-1.223-182.437199.433.2844.454
Cash At End Of Period 29.33534.64935.872218.30918.87915.595